Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,764 | 136,992 | 166,826 | 73,165 | 53,642 |
| Marketable Securities | 30,130 | 46,695 | 49,728 | 70,683 | 111,391 |
| Receivables | 10,265 | 1,173 | N/A | N/A | N/A |
| Inventories | 14,944 | 3,113 | 2,314 | N/A | N/A |
| TOTAL | $186,860 | $206,975 | $236,776 | $147,498 | $168,572 |
| Non-Current Assets | |||||
| PPE Net | 76,749 | 54,592 | 39,135 | 28,630 | 11,819 |
| Intangibles | 19,954 | 19,954 | 19,954 | 19,954 | 19,954 |
| Other Non-Current Assets | 13,327 | 26,216 | 37,672 | 14,919 | 14,236 |
| TOTAL | $110,030 | $100,762 | $96,761 | $63,503 | $46,009 |
| Total Assets | $296,890 | $307,737 | $333,537 | $211,001 | $214,581 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,041 | 8,761 | 10,939 | 3,479 | 508 |
| Accrued Expenses | 15,638 | 13,705 | 16,228 | 17,315 | 23,947 |
| TOTAL | $23,941 | $22,534 | $27,822 | $21,503 | $25,171 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 588 | 588 | 588 |
| Other Non-Current Liabilities | 176,000 | 176,000 | 176,000 | 176,000 | 150,000 |
| TOTAL | $176,638 | $176,264 | $181,038 | $180,902 | $155,074 |
| Total Liabilities | $200,579 | $198,798 | $208,860 | $202,405 | $180,245 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 148,550 | 145,669 | 142,964 | 127,407 | 126,389 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -696,866 | -669,683 | -637,581 | -598,331 | -566,459 |
| Other shareholders' equity | -1,087 | -465 | -437 | -72 | -226 |
| TOTAL | $96,311 | $108,939 | $124,677 | $8,596 | $34,336 |
| Total Liabilities And Equity | $296,890 | $307,737 | $333,537 | $211,001 | $214,581 |